Molina Healthcare, Inc. filings document the regulatory record for a managed healthcare company serving Medicaid, Medicare and state insurance marketplace programs. Its 8-K reports disclose operating results, premium revenue and earnings guidance, Regulation FD investor presentations, material agreements, direct financial obligations, impairment charges and senior unsecured note financing.
The company's proxy and governance filings cover annual meeting proposals, director and executive compensation matters, equity incentive plan authorization and amendments to charter or bylaw provisions such as stockholder special-meeting rights. The filing record also describes capital-structure terms, credit agreement covenants, risk-factor references and shareholder voting outcomes.
WOLF DALE B reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Dale B. Wolf received an equity grant of 237 shares of common stock, awarded through a trust, as part of his board compensation. The grant was made under the 2025 Equity Incentive Plan, valued at $55,000 based on the $232.55 closing price on July 1, 2026, bringing indirect holdings to 15,633 shares.
Schapiro Richard M reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Richard M. Schapiro received a stock grant as part of his board compensation. He was awarded 237 shares of common stock on July 1, 2026 under the company’s 2025 Equity Incentive Plan, valued at $55,000 based on the closing price of $232.55 per share.
The filing explains this is one quarter of an annual equity award of $220,000 to each director, granted in four equal quarterly installments. Following this award, Schapiro directly holds 12,311 shares of Molina Healthcare common stock, reflecting ongoing, routine equity-based compensation for his service as a director.
ROMNEY RONNA reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Ronna Romney received a stock grant through her revocable trust as part of routine board compensation. The trust was awarded 237 shares of common stock under the 2025 Equity Incentive Plan, based on the July 1, 2026 closing price of $232.55 per share.
This quarterly grant represents an equity value of $55,000, one quarter of a $220,000 annual equity award for directors. Following this award, the Ronna Romney Revocable Trust holds a total of 17,869 Molina Healthcare shares, reflecting ongoing compensation rather than an open-market purchase or sale.
ORLANDO STEVEN J reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Steven J. Orlando, through the Orlando Family Trust, received a grant of 237 shares of common stock on July 1, 2026 under the company’s 2025 Equity Incentive Plan. The grant represents a quarterly equity award valued at $55,000, based on the $232.55 closing share price, as part of a $220,000 annual director equity package. Following this award, the trust holds 17,967 shares, and an additional 1,500 shares are held indirectly through Orlando’s 401(k) plan.
Lockhart Stephen H reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Stephen H. Lockhart received a stock award rather than making an open-market purchase. He was granted 237 shares of common stock on July 1, 2026 at a reference price of $232.55 per share under the company’s 2025 Equity Incentive Plan.
This grant represents one quarterly installment of an annual equity award valued at $220,000 for each director, with $55,000 granted on the first day of each quarter based on the closing share price that day. After this award, Lockhart directly holds 4,384 Molina Healthcare shares.
GROHOWSKI LEO P reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Leo P. Grohowski received a grant of 237 shares of Common Stock on July 1, 2026 as compensation for his board service. The shares were issued under Molina Healthcare’s 2025 Equity Incentive Plan at a price of $232.55 per share, based on the closing market price that day.
This quarterly equity award represents one quarter of an annual director equity value of $220,000, with $55,000 granted each quarter. Following this grant, Grohowski directly holds 1,542 shares of Molina Healthcare common stock.
SOISTMAN FRANCIS S JR reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Francis S. Soistman Jr. received a grant of 237 shares of common stock on July 1, 2026. The shares were awarded under the company’s 2025 Equity Incentive Plan as part of his director compensation, based on the stock’s closing price of $232.55.
The filing notes that each director’s annual equity award is valued at $220,000, with $55,000 granted on the first day of each quarter. Following this grant, Soistman directly holds 907 shares of Molina Healthcare common stock.
BRASIER BARBARA L reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare, Inc. director Barbara L. Brasier received a grant of 237 shares of common stock as part of her director compensation. The shares were granted under the company’s 2025 Equity Incentive Plan, based on the July 1, 2026 closing price of $232.55 per share.
The award represents one quarterly installment of a $220,000 annual equity award for each director, with this quarter’s portion set at $55,000. Following this grant, Brasier directly holds 5,818 shares of Molina Healthcare common stock, reflecting routine, compensation-related equity ownership rather than an open-market purchase or sale.
Molina Healthcare Chief Operating Officer James Woys acquired 144 shares of common stock under the company’s 2019 Employee Stock Purchase Plan. The shares were purchased at $147.51 per share, equal to 85% of the lower closing price of $173.54 during the offering period. Following this ESPP acquisition, Woys directly holds 90,178 shares of Molina Healthcare common stock.
Molina Healthcare, Inc. Chief Legal Officer Jeff D. Barlow increased his direct stake through the company’s employee stock purchase plan. He acquired 138 shares of common stock on June 30, 2026 at a plan price of $147.51 per share, bringing his direct holdings to 67,313 shares.
The shares were bought under Molina’s 2019 Employee Stock Purchase Plan, which sets the purchase price at 85% of the lower closing price on January 1, 2026 or June 30, 2026, using a reference price of $173.54. Footnotes also show that a portion of his broader equity awards will vest in tranches from March 2027 through March 2029.